Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCKOY, QUINCY ANDRE | 1 | 70.0% | +39.5% |
| BELL, SARA ELIZABETH | 1 | 68.5% | +39.7% |
| MOU, LIYUAN | 1 | 43.5% | +57.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18554158 | CANCER TREATMENT USING PARP INHIBITORS AND PLK1 INHIBITORS | MCKOY, QUINCY ANDRE | — |
| 17598665 | PLK1 INHIBITORS AND PSA LEVELS IN PROSTATE CANCER | BELL, SARA ELIZABETH | — |
| 17433440 | ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUSCLE AND PROSTATE CELL PROLIFERATION | MOU, LIYUAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18554158 | CANCER TREATMENT USING PARP INHIBITORS AND PLK1 INHIBITORS | MCKOY, QUINCY ANDRE | — |
| 17598665 | PLK1 INHIBITORS AND PSA LEVELS IN PROSTATE CANCER | BELL, SARA ELIZABETH | — |
| 17433440 | ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUSCLE AND PROSTATE CELL PROLIFERATION | MOU, LIYUAN | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1625 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18554158 | CANCER TREATMENT USING PARP INHIBITORS AND PLK1 INHIBITORS | MCKOY, QUINCY ANDRE | 1626 | §103§112 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 17598665 | PLK1 INHIBITORS AND PSA LEVELS IN PROSTATE CANCER | BELL, SARA ELIZABETH | 1625 | §103§112 | Final Rejection | — | Pending | Sep 27, 2021 |
| 17433440 | ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUSCLE AND PROSTATE CELL PROLIFERATION | MOU, LIYUAN | 1628 | §103§112 | Final Rejection | — | Pending | Aug 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial